MFDS — authorised 30 November 1979
- Marketing authorisation holder: FOUGERA PHARMS
- Status: likely_approved
🇰🇷 Ocuzolin in South Korea
MFDS authorised Ocuzolin on 30 November 1979
Marketing authorisation
Ocuzolin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Ophthalmology approved in South Korea
Frequently asked questions
Is Ocuzolin approved in South Korea?
Yes. MFDS authorised it on 30 November 1979.
Who is the marketing authorisation holder for Ocuzolin in South Korea?
FOUGERA PHARMS holds the South Korean marketing authorisation.